☆ 4.8 Meeting Abstract

The Toll-Like-Receptor 9 Agonist DIMS0150 Demonstrates Therapeutic Efficacy for the Patient Reported Outcome Measures PRO-2 and Clinpro in Moderate to Severe Active Ulcerative Colitis

GASTROENTEROLOGY (2016)

Journal

GASTROENTEROLOGY

Volume 150, Issue 4, Pages S773-S773

Publisher

W B SAUNDERS CO-ELSEVIER INC

DOI: 10.1016/S0016-5085(16)32621-X

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

The Toll-Like-Receptor 9 Agonist DIMS0150 Demonstrates Therapeutic Efficacy for the Patient Reported Outcome Measures PRO-2 and Clinpro in Moderate to Severe Active Ulcerative Colitis

Journal

GASTROENTEROLOGY

Publisher

W B SAUNDERS CO-ELSEVIER INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

The Toll-Like-Receptor 9 Agonist DIMS0150 Demonstrates Therapeutic Efficacy for the Patient Reported Outcome Measures PRO-2 and Clinpro in Moderate to Severe Active Ulcerative Colitis

Journal

GASTROENTEROLOGY

Publisher

W B SAUNDERS CO-ELSEVIER INC

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper